ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01322685
Recruitment Status : Unknown
Verified March 2011 by Taipei Medical University WanFang Hospital.
Recruitment status was:  Active, not recruiting
First Posted : March 24, 2011
Last Update Posted : March 24, 2011
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital

Brief Summary:
The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Condition or disease
Tuberculosis Lung Cancer

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
Study Start Date : July 2010
Estimated Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
Health Group
Tuberculosis Group
Tuberculosis or lung cancer group




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   17 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Health people Tuberculosis or lung cancer
Criteria

Inclusion Criteria:

  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion Criteria:

  • Women subjects are before or after the period within two days

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01322685


Locations
Taiwan
Taipei Medical University - WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Kuo-Sheng Hung Taipei Medical University WanFang Hospital

Responsible Party: Kuo-Sheng Hung, Department of Neurosurgery, WanFang Hospital
ClinicalTrials.gov Identifier: NCT01322685     History of Changes
Other Study ID Numbers: 99042
First Posted: March 24, 2011    Key Record Dates
Last Update Posted: March 24, 2011
Last Verified: March 2011

Keywords provided by Taipei Medical University WanFang Hospital:
Tuberculosis
Lung cancer

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections